Dividend
-
-
-
-
-
-
-
Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights
-
-
-
-
-
-
-
FDA approves ZYCUBO as first Menkes disease treatment
-
-
-
-
-
-
-
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Series A Financing
-
-
-
-
-
-
-
Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates
-
-
-
-
-
-
-
Sun Pharma to Acquire Checkpoint Therapeutics
-
-
-
-
-
-
-
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
-
-
-
-
-
-
-
Fortress Biotech (FBIO) Reduces Total Debt, Enters $35M Term Loan with Oaktree with Maturity in 2027
-
452,274 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

